NANOBIOTIX Provides Business Update and Financial Results for the First Half of 2023
Global licensing, co-development, and commercialization agreement with Janssen Pharmaceutica NV (“Janssen”) expands worldwide potential of novel r...
Stay updated with breaking news from Advanced Head. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Global licensing, co-development, and commercialization agreement with Janssen Pharmaceutica NV (“Janssen”) expands worldwide potential of novel r...
Global licensing, co-development, and commercialization agreement with Janssen Pharmaceutica NV (“Janssen”) expands worldwide potential of novel...
28.08.2023 - Patent Covers Multiple Component Vaccine for Both Prevention and Treatment ATLANTA, GA, Aug. 28, 2023 (GLOBE NEWSWIRE) - via NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines ... Seite 1
Reported €30.2 million in cash and cash equivalents as of March 31, 2023PARIS and CAMBRIDGE, Mass., May 17, 2023 -- NANOBIOTIX , a late-clinical stage biotechnology company pioneering... | May 17, 2023
SARASOTA (SNN TV) – Sarasota Memorial Health Care System is welcoming the first dedicated head and neck cancer and microvascular surgeon to First Physicians Group (FPG) network and the team of s